Unleash the Potential of Your Lyophilization and Bioprocessing Projects with Biopharma Group

Pharma and biotech companies in the UK, France, and Ireland, elevate your project success with Biopharma Group, your one-stop solution for lyophilization and bioprocessing needs.

Unparalleled Expertise & Scalable Solutions:

Biopharma Group goes beyond simply supplying equipment. They offer a comprehensive portfolio of capital equipment, from freeze dryers and cryopreservation storage to analytical instruments, all configurable to your specific requirements. Their team of product specialists, scientists, engineers, and renowned lyophilization experts provide unparalleled knowledge and support, ensuring you have the right tools for every stage of development. Whether you're scaling up or down, Biopharma Group adapts to your evolving needs.

Customizable Services & In-House R&D:

Unlike a one-size-fits-all approach, Biopharma Group's product specialists and scientific team work collaboratively to design configurable solutions tailored to your unique project. They don't just sell equipment; they become your trusted partner in achieving project and product development success.

Beyond Equipment - A Dedicated CDMO Partner:

The addition of Biopharma Group's in-house Contract Development & Manufacturing (CDMO) division empowers you with a comprehensive range of R&D and manufacturing services for lyophilized products and liquid formulations. This eliminates the need for multiple vendors, streamlining your workflow. Services include:

• Freeze Drying & Associated Services: From formulation and cycle development to pre- and post-lyophilization analysis, finished product manufacturing, and early phase clinical manufacturing.
• Proof of Concept Studies: Assess project feasibility before full-scale development.
• Dedicated Facilities: Biopharma Group offers low bio-burden suites, cytotoxic handling, and Category D labs for handling sensitive samples.
• Contract Manufacturing & Production: Scale your products from R&D to production or early phase clinical trials.

Investing in Your Future:

Biopharma Group is dedicated to continuous innovation and expansion. They are:

• Licensing their first early phase clinical trials GMP production facility for contract manufacturing.
• Expanding the capital equipment portfolio for bioprocessing.
• Building new Category D labs and expanding cytotoxic handling capabilities.
• Partnering with industry peers to develop dual-use formulations, reducing reliance on cold chain storage.

Partner with Biopharma Group, your end-to-end solution for lyophilization and bioprocessing success.

Get in touch today to request contact with a specialist to discuss your requirements and explore how the Biopharma Group team can help you achieve your production and project goals.